A new report by EY has revealed that despite tariff uncertainty, the medtech industry has recorded its seventh successive year of top-line growth to reach a valuation of $584bn in the 12 months ended ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback